Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Kite’s Huston joins Galapagos as CFO, COO

Plus: Burgess to head BD at Cerevel, and updates from Mablink, PathAI and Berlin

June 15, 2023 11:29 PM UTC

Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) hired Thad Huston as CFO and COO, effective July 1. Huston will join the company from Kite Pharma Inc., part of Gilead Sciences Inc. (NASDAQ:GILD), where he is global head of finance and corporate operations. Huston joins the company as CEO Paul Stoffels works to shift its direction and focus; Stoffels discussed his vision for the company on The BioCentury Show in April.

Neuroscience disease company Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) hired Paul Burgess as chief business development and strategic operations officer, effective June 20. Burgess was COO and chief legal officer at Translate Bio Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article